New drug tested for safety in healthy people first
NCT ID NCT07531316
First seen Apr 20, 2026 · Last updated Apr 30, 2026 · Updated 4 times
Summary
This early-stage study will test the safety and tolerability of an experimental drug called VVZ-2471 in 60 healthy adults who show high impulsivity. Participants will receive either the drug or a placebo, and researchers will monitor side effects and how well the drug is tolerated. The results will help design future studies for people who use substances.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY CONTROLS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VCU Institute for Drug and Alcohol Studies
Richmond, Virginia, 23219, United States
Conditions
Explore the condition pages connected to this study.